| Browse All

Altimmune, Inc. (ALT)

Healthcare | Biotechnology | Gaithersburg, United States | NasdaqGM
3.50 USD -0.01 (-0.285%) ⇩ (April 17, 2026, 4 p.m. EDT)
After hours: 3.46 -0.04 (-0.040%) ⇩ (April 17, 2026, 7:57 p.m. EDT)

Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 11, 2026, 4:03 p.m. EDT

ALT is currently trading at a significant discount to its 52-week high and has shown a volatile price movement over the last two weeks. Despite some positive analyst sentiment and recent insider buying, the stock has a high overall risk profile and is trading below its 50-day average. The lack of dividends and negative earnings make it less attractive for long-term investors. Short-term traders might consider the recent dip as a potential buying opportunity, but the mixed options activity suggests uncertainty. Overall, the stock appears to be in a speculative phase with limited fundamental support.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.229334
MSTL0.443694
AutoETS0.455527
AutoTheta0.463528

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 45%
H-stat 7.59
Ljung-Box p 0.000
Jarque-Bera p 0.320
Excess Kurtosis -1.05
Attribute Value
Sector Healthcare
Ex Dividend Date 2017-01-19
Debt to Equity Ratio 15.869
Market Cap 455,368,128
Forward P/E -2.57
Beta 0.34
Website https://altimmune.com

As of April 11, 2026, 4:03 p.m. EDT: The options activity indicates mixed sentiment. Call options are showing some interest in strikes above the current price, especially around the 3.5 and 4.0 strike levels, with increased open interest and implied volatility. However, put options are also showing significant activity, particularly around the 3.0 strike level, suggesting some bearish sentiment. The overall volatility is relatively low, but there are signs of directional bets, especially with the higher implied volatility on puts. This could indicate potential for short-term price movements, either upward or downward, depending on the underlying news and market conditions.


Info Dump

Attribute Value
52 Week Change -0.26931107
Address1 910 Clopper Road
Address2 Suite 201S
All Time High 137.7
All Time Low 1.51
Ask 3.53
Ask Size 5
Audit Risk 2
Average Daily Volume10 Day 2,166,240
Average Daily Volume3 Month 3,849,122
Average Volume 3,849,122
Average Volume10Days 2,166,240
Beta 0.338
Bid 3.46
Bid Size 5
Board Risk 5
Book Value 2.028
City Gaithersburg
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 8
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.5
Current Ratio 18.55
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 3.59
Day Low 3.42
Debt To Equity 15.869
Display Name Altimmune
Dividend Date 1,536,883,200
Earnings Call Timestamp End 1,772,717,400
Earnings Call Timestamp Start 1,772,717,400
Earnings Timestamp 1,772,717,400
Earnings Timestamp End 1,778,589,000
Earnings Timestamp Start 1,778,589,000
Ebitda -94,377,000
Ebitda Margins 0.0
Enterprise To Ebitda -2.304
Enterprise To Revenue 5,304.316
Enterprise Value 217,476,944
Eps Current Year -1.17
Eps Forward -1.36429
Eps Trailing Twelve Months -1.0
Esg Populated 0
Ex Dividend Date 1,484,870,400
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.8195
Fifty Day Average Change -0.31949997
Fifty Day Average Change Percent -0.08364969
Fifty Two Week Change Percent -26.931107
Fifty Two Week High 7.73
Fifty Two Week High Change -4.23
Fifty Two Week High Change Percent -0.5472186
Fifty Two Week Low 2.87
Fifty Two Week Low Change 0.6300001
Fifty Two Week Low Change Percent 0.21951224
Fifty Two Week Range 2.87 - 7.73
Financial Currency USD
First Trade Date Milliseconds 1,495,805,400,000
Float Shares 129,145,185
Forward Eps -1.36429
Forward P E -2.565437
Free Cashflow -38,722,124
Full Exchange Name NasdaqGM
Full Time Employees 57
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.0
Gross Profits -66,391,000
Has Pre Post Market Data 1
Held Percent Insiders 0.0061799996
Held Percent Institutions 0.42539
Implied Shares Outstanding 130,105,177
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ir Website http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,536,883,200
Last Split Factor 1:30
Long Business Summary Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Long Name Altimmune, Inc.
Market us_market
Market Cap 455,368,128
Market State CLOSED
Max Age 86,400
Message Board Id finmb_4866807
Most Recent Quarter 1,767,139,200
Net Income To Common -88,093,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 454,067,067
Number Of Analyst Opinions 10
Open 3.55
Operating Cashflow -67,535,000
Operating Margins -1,111.2692
Overall Risk 5
Payout Ratio 0.0
Peg Ratio 32.62
Phone 240 654 1450
Post Market Change -0.03999996
Post Market Change Percent -1.142856
Post Market Price 3.46
Post Market Time 1,776,470,222
Previous Close 3.51
Price Eps Current Year -2.9914532
Price Hint 4
Price To Book 1.7258382
Price To Sales Trailing12 Months 11,106.54
Profit Margins 0.0
Quick Ratio 18.35
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.00999999
Regular Market Change Percent -0.2849
Regular Market Day High 3.59
Regular Market Day Low 3.42
Regular Market Day Range 3.42 - 3.59
Regular Market Open 3.55
Regular Market Previous Close 3.51
Regular Market Price 3.5
Regular Market Time 1,776,456,000
Regular Market Volume 2,854,212
Return On Assets -0.28173
Return On Equity -0.5057
Revenue Growth 4.2
Revenue Per Share 0.0
Sand P52 Week Change 0.38150132
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 4
Shares Outstanding 130,105,177
Shares Percent Shares Out 0.22479999
Shares Short 29,248,014
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 25,499,023
Short Name Altimmune, Inc.
Short Percent Of Float 0.2252
Short Ratio 8.11
Source Interval 15
State MD
Symbol ALT
Target High Price 28.0
Target Low Price 1.0
Target Mean Price 18.0
Target Median Price 20.0
Total Cash 273,456,000
Total Cash Per Share 2.102
Total Debt 35,688,000
Total Revenue 41,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.0
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 4.104875
Two Hundred Day Average Change -0.6048751
Two Hundred Day Average Change Percent -0.1473553
Type Disp Equity
Volume 2,854,212
Website https://altimmune.com
Zip 20,878